ANNOVERA

At a glance

Key dates

1. Approval

   FDA approval date of this drug product.

   Aug 10, 2018

   8 yr ago

2. Today

3. Patent 10632066 expires

   Listed method-of-use patent (U-2787) expiration.

   Feb 01, 2039

   in 12 yr 10 mo

4. Patent 10632066 expires

   Listed method-of-use patent (U-2786) expiration.

   Feb 01, 2039

   in 12 yr 10 mo

5. Patent 10765628 expires

   Listed method-of-use patent (U-2786) expiration.

   Feb 01, 2039

   in 12 yr 10 mo

6. Patent 10765628 expires

   Listed method-of-use patent (U-2787) expiration.

   Feb 01, 2039

   in 12 yr 10 mo

7. Patent 10780047 expires

   Listed method-of-use patent (U-2787) expiration.

   Feb 01, 2039

   in 12 yr 10 mo

8. Patent 10780047 expires

   Listed method-of-use patent (U-2786) expiration.

   Feb 01, 2039

   in 12 yr 10 mo

9. Patent 10918649 expires

   Listed drug product patent expiration.

   Jun 21, 2039

   in 13 yr 2 mo

10. Patent 10925882 expires

    Listed drug product patent expiration.

    Jun 21, 2039

    in 13 yr 2 mo

11. Patent 10940157 expires

    Listed drug product patent expiration.

    Jun 21, 2039

    in 13 yr 2 mo

12. Patent 11529308 expires

    Listed drug product patent expiration.

    Jun 21, 2039

    in 13 yr 2 mo

13. Patent 11850251 expires

    Listed method-of-use patent (U-3785) expiration.

    Jun 21, 2039

    in 13 yr 2 mo

14. Patent 12303518 expires

    Listed drug product patent expiration.

    Jun 21, 2039

    in 13 yr 2 mo

Pharmaceutical detail

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (12)